A gene mutation that is believed to have safeguarded some people in 14th century Europe from the bubonic plague today may be protecting HIV patients co-infected with hepatitis C from potentially fatal liver scarring, says ...
Dec 3, 2018
0
2
I mentioned to a friend, a gay man nearing 60, that World AIDS Day, which has been observed on Dec. 1 since 1988, was almost upon us. He had no idea that World AIDS Day still exists.
Nov 30, 2018
0
0
A new commentary from National Institutes of Health scientists asserts that engaging men in HIV prevention and care is essential to the goal of ending the HIV pandemic. The article by Adeola Adeyeye, M.D., M.P.A., and David ...
Nov 29, 2018
0
1
From diagnosis of HIV to successful viral suppression: in a rapid communication published in Eurosurveillance today, ECDC and co-authors from Public Health England and The National AIDS Trust summarise the progress towards ...
Nov 29, 2018
0
0
On Monday, geneticists were just converging on Hong Kong for a long-planned meeting to discuss the future of gene editing. But before many had even collected their name tags, it seemed the future had already arrived.
Nov 27, 2018
1
5
With nearly two million new infections and one million associated deaths each year, the HIV (human immunodeficiency virus) pandemic is alive and well. Thirty-seven million people are now living with HIV, more than half of ...
Nov 19, 2018
0
2
States that aggressively target intimate partner violence (IPV) in their health care systems have lower rates of HIV infection among women, according to a new study led by researchers at the Yale School of Public Health.
Nov 19, 2018
0
5
New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the hepatitis C Virus (HCV).
Nov 14, 2018
0
24
According to new research from The Wistar Institute, the S100A14 protein is expressed at higher levels in people who inject drugs and remain uninfected despite many years of high-risk, needle sharing behavior in areas with ...
Nov 13, 2018
0
2
The latest World Health Organization (WHO) recommendations published in July 2018 advocate first-line treatment of HIV infection using dolutegravir (DTG) as an alternative to treatment with efavirenz at 400 mg (EFV400). Until ...
Nov 1, 2018
0
0
